WiseGuyReports have announced the addition of a new report titled “Biosimulation Market – Forecasts from 2017 to 2022”.
Biosimulation is used in the healthcare sector for model-based calculation of biological systems. It is helpful in making commercial decisions regarding the benefits of bringing a specific drug to market. In 2022, the market for biosimulation is expected to reach US$3,435 million, increasing from US$1,476 million in 2017. During this period it is projected to grow at a CAGR of 18.40%. Factors driving the biosimulation market growth are increased medical research and development across emerging economies, technological advancement in drug development processes, robust pace of clinical trials and a favourable regulatory environment in developed regions like the US and Europe. Rising demand for reduced drug development costs coupled with penetration of digital and computer technology and improvement in modeling tools has fuelled further market growth. Geographically, North America is the expected to remain the largest biosimulation market over the projected period followed by Europe.
Research Methodology
This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.
Market Dynamics
In this section, the entire market is explained along with various drivers, restraints, and opportunities which exist in the current market. This section of the report also provides product pipeline, industry value chain analysis, and innovations in the market. Various regulations in the industry along with a scenario analysis have also been covered as a part of this report section.
Segmentation
Biosimulation market has been segmented on the basis of type, application, end user and geography as follows:
By Type
Software
Services
By Application
Drug Development
Drug Discovery
Others
By End-User
Pharmaceutical Companies
Academic Institutes
Research Organizations
Others
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
The Middle East and Africa
Asia Pacific
Market Players
Request Sample Report at https://www.wiseguyreports.com/sample-request/1283827-biosimulation-market-forecasts-from-2017-to-2022
Table of Content
- Introduction
- Research Methodology
- Executive Summary
- Market Dynamics
- Biosimulation Market Forecast by Type (US$ million)
- Biosimulation Market Forecast by Application (US$ million)
- Biosimulation Market Forecast by End-User (US$ million)
- Biosimulation Market by Geography (US$ million)
- Competitive Intelligence
- Company Profiles
10.1. Rhenovia Pharma Ltd.
10.2. Certara USA, Inc.
10.3. Simulation Plus Inc.
10.4. Dassault SA
10.5. Schrodinger Inc.
10.6. Advanced Chemistry Development, Inc.
10.7. Physiomics PLC
10.8. Chemical Computing Group
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
